| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/27/1992 | CA2063866A1 Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| 09/26/1992 | CA2063742A1 Angiotensin ii antagonists incorporating a nitrogen containing six membered ring heterocycle |
| 09/26/1992 | CA2063172A1 4-aryl-thiazole or imidazole derivatives |
| 09/26/1992 | CA2061477A1 Analgesic composition containing beta-carotene |
| 09/23/1992 | EP0505122A1 Alpha, alpha-dialkylbenzyl derivatives |
| 09/23/1992 | EP0505098A1 Imidazole derivatives bearing acidic functional groups as angiotensin II antagonists |
| 09/23/1992 | EP0505058A1 Thienopyridine derivatives and pharmaceutical compositions containing them |
| 09/23/1992 | EP0504862A1 Composition for treating the cutaneous atrophy associated with topical steroid use comprising a salt of C3-7 alpha-hydroxy carboxylic acid |
| 09/23/1992 | EP0504799A1 Mixted pyridine-2,4- and 2,5-dicarboxylic acid diamides, process for their preparation, their use as well as medicaments based on these compounds |
| 09/23/1992 | EP0504695A1 New carboxamides, their preparation and pharmaceutical compositions containing them |
| 09/23/1992 | EP0504679A1 New imidazopyridines as serotonergic 5-HT3 antagonists |
| 09/23/1992 | EP0504236A1 Utilisation of extracts of algae for the preparation of pharmaceutical, cosmetic, food or agricultural compositions. |
| 09/23/1992 | CN1064679A 醌类衍生物 Quinone derivatives |
| 09/22/1992 | WO1992016544A1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it |
| 09/22/1992 | US5149786 Free of adrenal and brain derived proteins, useful for treating perkinson's disease and schizophrenia |
| 09/22/1992 | US5149691 Applying to dental tissue; synergistic |
| 09/22/1992 | CA2102689A1 Novel caffeic acid derivative, oraposide, and cosmetic or pharmaceutic, especially dermatological, composition containing it |
| 09/22/1992 | CA2061662A1 Novel carboxylic amides |
| 09/22/1992 | CA1307793C Aralkyl esters and processes for their preparation |
| 09/22/1992 | CA1307790C Ethers |
| 09/22/1992 | CA1307739C Anti-inflammatory compositions |
| 09/21/1992 | CA2063185A1 Benzo-fused lactams that promote the release of growth hormone |
| 09/20/1992 | CA2063122A1 Imidazole derivatives bearing acidic functional groups as angiotensin ii antagonists |
| 09/19/1992 | CA2063177A1 Mixed pyridine-2,4- and -2,5-dicarboxamides, a process for preparing them, the use thereof and pharmaceuticals based on these compounds |
| 09/17/1992 | WO1992015686A1 Modified factor vii |
| 09/17/1992 | WO1992015615A1 Serum calcium depressing factor |
| 09/17/1992 | WO1992015613A1 Improved preparation of cat dander allergens for immunotherapeutic purposes and uses therefor |
| 09/17/1992 | WO1992015606A1 New inhibitors of endothelial cell proliferation |
| 09/17/1992 | WO1992015582A1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-c]QUINOLIN-4-AMINES |
| 09/17/1992 | WO1992015567A1 Imidazole-derivatives having agonistic or antagonistic activity on the histamine h3-receptor |
| 09/17/1992 | WO1992015565A1 Nmda antagonists |
| 09/17/1992 | WO1992015558A1 Indian derivative and thromboxane antagonist containing the same |
| 09/17/1992 | WO1992015551A1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents |
| 09/17/1992 | WO1992015323A1 Protein-induced morphogenesis |
| 09/17/1992 | WO1992015319A1 Hiv protease inhibitors |
| 09/17/1992 | WO1992015309A1 Antiviral nucleoside combination |
| 09/17/1992 | WO1992015306A1 Use of nicotinic analogs for treatment of degenerative diseases of the nervous system |
| 09/17/1992 | WO1992015301A1 Treatment of hypertension and peripheral vascular diseases |
| 09/17/1992 | WO1992015292A1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 09/17/1992 | WO1992013553A3 Method and agents for promoting wound healing |
| 09/17/1992 | WO1992010504A3 Phosphonic acid derivatives useful as antiinflammatory agents |
| 09/17/1992 | DE4108351A1 Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel New leukotriene b (Down Arrow) 4 (down arrow) derivatives, process for their production and their use as drug |
| 09/17/1992 | CA2362719A1 Synthesis of nicotinic analogs useful for the treatment of degenerative diseases of the nervous system |
| 09/17/1992 | CA2105171A1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents |
| 09/17/1992 | CA2104946A1 Imidazole-derivatives having agonistic or antagonistic activity on the histamine h3-receptor |
| 09/16/1992 | WO1992016623A2 Receptors for bombesin-like peptides |
| 09/16/1992 | EP0504064A1 Novel thrombin inhibitors |
| 09/16/1992 | EP0503844A1 Thienopyridine derivatives and pharmaceutical compositions containing them |
| 09/16/1992 | EP0503838A2 Heterocyclic compounds bearing acidic functional groups as angiotensin II antagonists |
| 09/16/1992 | EP0503828A1 Cosmetics |
| 09/16/1992 | EP0503785A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use |
| 09/16/1992 | EP0503710A2 Flunarizine containing anti-neoplastic compositions |
| 09/16/1992 | EP0503563A2 Novel 8-substituted purines as selective adenosine receptor agents |
| 09/16/1992 | EP0503426A1 Quinone derivatives |
| 09/16/1992 | EP0503349A1 Hydrazone derivatives, their preparation and use |
| 09/16/1992 | EP0503297A1 GLIA activating factor and its production |
| 09/16/1992 | EP0503203A1 Novel thrombin inhibitors |
| 09/16/1992 | EP0503162A1 Azole derivatives, process for their preparation and their application |
| 09/16/1992 | CA2105306A1 Receptors for bombesin-like peptides |
| 09/16/1992 | CA2063039A1 Use of phosphatidylserine and its derivatives in degenerative pathologies also associated with immune disfunctions |
| 09/16/1992 | CA2062853A1 Hydrazone derivatives, their preparation and use |
| 09/15/1992 | WO1992016228A1 TGF-β1/β2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 09/15/1992 | US5147880 Estrogenic and antiestrogenic activity |
| 09/15/1992 | US5147862 Administering a 1,3-glucan |
| 09/15/1992 | US5147652 Alpha ketoaldehydes |
| 09/15/1992 | CA2105877A1 Tgf-.beta.1/.beta.2: novel chimeric transforming growth factor-beta |
| 09/15/1992 | CA1307537C N-naphthoylglycines as aldose reductase inhibitors |
| 09/15/1992 | CA1307466C Inhibition of protein kinase c by long-chain bases |
| 09/14/1992 | WO1992016526A1 Thiazole derivatives |
| 09/14/1992 | CA2105981A1 Thiazole derivatives |
| 09/13/1992 | WO1992016504A1 New leukotriene b4 derivatives, method for preparing them and their use as drugs |
| 09/13/1992 | CA2082818A1 Leukotriene b4 derivatives, method for preparing them and their use as drugs |
| 09/12/1992 | CA2062263A1 Quinone derivatives |
| 09/09/1992 | WO1992015579A1 Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
| 09/09/1992 | EP0502725A2 Substituted fused pyrimidinones |
| 09/09/1992 | EP0502599A1 Use of IL-4 to enhance the reparitive phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals |
| 09/09/1992 | EP0502575A1 Substituted 1-(2H)-isoquinolinones |
| 09/09/1992 | EP0502314A1 Benzimidazol, medicaments containing them and process for their preparation |
| 09/09/1992 | EP0502171A1 Composition for inducing granulocyte production or b cell production in peripheral blood |
| 09/09/1992 | EP0502124A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 09/09/1992 | EP0502117A1 Polymers with alkyl- or heteroalkyl-aryl backbone and pharmaceutical compositions incorporating same |
| 09/09/1992 | EP0502106A1 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
| 09/09/1992 | EP0305400B1 A composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine |
| 09/09/1992 | CN1064277A 5-(substituted amino)-1,2,4-triazolo (1,5-a) pyrimidine derivatives |
| 09/09/1992 | CN1064275A Imidazopyridine paf/h1 antagonists |
| 09/09/1992 | CN1064273A Benzene derivatives having ngf production-promoting activity |
| 09/09/1992 | CN1064271A 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
| 09/09/1992 | CN1064269A 4-pyrimdinone derivatives, their preparation and their application in therapy |
| 09/09/1992 | CA2105655A1 Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
| 09/09/1992 | CA2061891A1 Flunarizine containing anti-neoplastic compositions |
| 09/08/1992 | WO1992015593A1 New imidazopyridines as serotonergic 5-ht3 antagonists |
| 09/08/1992 | US5145872 Enzyme inhibitors, analgesics |
| 09/08/1992 | US5145863 Porphyrin compounds |
| 09/08/1992 | US5145857 Hmg-coa reductase-inhibiting substituted amino-pyridines |
| 09/08/1992 | US5145680 Vitronectin solution |
| 09/08/1992 | US5145676 Method and agents for promoting wound healing |
| 09/08/1992 | CA2082414A1 Imidazopyridines as serotonergic 5-ht3 antagonists |
| 09/08/1992 | CA1307289C2 Peptidylaminodiols |
| 09/08/1992 | CA1307288C Chemical compounds |
| 09/08/1992 | CA1307271C (1h-azo-1-ylmethyl)substituted benzotriazole derivatives |